» Articles » PMID: 28868615

Mechanisms of Weight Loss and Improved Metabolism Following Bariatric Surgery

Overview
Specialty Science
Date 2017 Sep 5
PMID 28868615
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Bariatric surgery is increasingly recognized as one of the most effective interventions to help patients achieve significant and sustained weight loss, as well as improved metabolic and overall health. Unfortunately, the cellular and physiological mechanisms by which bariatric surgery achieves weight loss have not been fully elucidated, yet are critical to understanding the central role of the intestinal tract in whole-body metabolism and to developing novel strategies for the treatment of obesity. In this review, we provide an overview of potential mechanisms contributing to weight loss, including effects on regulation of energy balance and both central and peripheral nervous system regulation of appetite and metabolism. Moreover, we highlight the importance of the gastrointestinal tract, including alterations in bile acid physiology, secretion of intestinally derived hormones, and the microbiome, as a potent mediator of improved metabolism in postbariatric patients.

Citing Articles

Impact of a very low-calorie ketogenic diet on metabolic and microbiota outcomes in post-bariatric patients and bariatric-Naïve individuals: A comparative pilot study.

Ernesti I, Massari M, Cipriani F, Masi D, Glaser K, Genco M Diabetes Obes Metab. 2025; 27(4):1950-1959.

PMID: 39791264 PMC: 11885101. DOI: 10.1111/dom.16187.


Long-Term Follow-Up After Bariatric Surgery: Key to Successful Outcomes in Obesity Management.

Budny A, Janczy A, Szymanski M, Mika A Nutrients. 2025; 16(24.

PMID: 39771020 PMC: 11679841. DOI: 10.3390/nu16244399.


A False Dichotomy: Rethinking the Debate Around Pharmacotherapy vs Bariatric Metabolic Surgery in Obesity Treatment.

Jones-Whiting L, Aradaib M, Mahawar K Obes Surg. 2024; 34(11):3939-3940.

PMID: 39384704 DOI: 10.1007/s11695-024-07537-2.


Outcomes of Single Anastomosis Sleeve Ileal (SASI) Bypass as an Alternative Procedure in Treating Obesity: An Updated Systematic Review and Meta-Analysis.

Ataya K, Patel N, Aljaafreh A, Melebari S, Yang W, Guillen C Obes Surg. 2024; 34(9):3285-3297.

PMID: 39060638 DOI: 10.1007/s11695-024-07366-3.


Inhibition of somatostatin enhances the long-term metabolic outcomes of sleeve gastrectomy in mice.

Kleiman D, Arad Y, Azulai S, Baker A, Bergel M, Elad A Mol Metab. 2024; 86:101979.

PMID: 38945296 PMC: 11278880. DOI: 10.1016/j.molmet.2024.101979.


References
1.
Halperin F, Ding S, Simonson D, Panosian J, Goebel-Fabbri A, Wewalka M . Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg. 2014; 149(7):716-26. PMC: 4274782. DOI: 10.1001/jamasurg.2014.514. View

2.
Ballsmider L, Vaughn A, David M, Hajnal A, Di Lorenzo P, Czaja K . Sleeve gastrectomy and Roux-en-Y gastric bypass alter the gut-brain communication. Neural Plast. 2015; 2015:601985. PMC: 4333325. DOI: 10.1155/2015/601985. View

3.
Scott W, Batterham R . Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. Am J Physiol Regul Integr Comp Physiol. 2011; 301(1):R15-27. DOI: 10.1152/ajpregu.00038.2011. View

4.
Courcoulas A, Belle S, Neiberg R, Pierson S, Eagleton J, Kalarchian M . Three-Year Outcomes of Bariatric Surgery vs Lifestyle Intervention for Type 2 Diabetes Mellitus Treatment: A Randomized Clinical Trial. JAMA Surg. 2015; 150(10):931-40. PMC: 4905566. DOI: 10.1001/jamasurg.2015.1534. View

5.
Chandarana K, Gelegen C, Karra E, Choudhury A, Drew M, Fauveau V . Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY. Diabetes. 2011; 60(3):810-8. PMC: 3046841. DOI: 10.2337/db10-0566. View